Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Medicskin HoldingsHKSE:08307 54 FCF Margin % is 26.05% as of Mar. 2026, which is 174% above its 10-year median of 9.49. GuruFocus rates HKSE:08307 with a GF Score™ of 54/100 and a GF Value™ of HK$0.18 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 666 Healthcare Providers & Services companies, Medicskin Holdings ranks better than 69.82% on this metric.
The historical rank and industry rank for Medicskin Holdings's FCF Margin % or its related term are showing as below:
HKSE:08307'
s FCF Margin % Range Over the Past 10 Years
Min: -58.28 Med: 9.49 Max: 27.49
Current: 8.87
During the past 13 years, the highest FCF Margin % of Medicskin Holdings was 27.49%. The lowest was -58.28%. And the median was 9.49%.
HKSE:08307's FCF Margin % is ranked better than 69.82% of 666
companies
in the Healthcare Providers & Services industry
Industry Median: 3.005
vs HKSE:08307: 8.87
The historical data trend for Medicskin Holdings's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:08307 vs HCA, THC, DVA: FCF Margin % Comparison
For the Medical Care Facilities subindustry, Medicskin Holdings's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medicskin Holdings FCF Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Medicskin Holdings's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Medicskin Holdings's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medicskin Holdings (HKSE:08307) has a FCF Margin % of 26.05% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Medicskin Holdings and its competitors. This is 174% above median its historical median of 9.49. According to the industry distribution chart, Medicskin Holdings ranks #201 out of 666 companies in the Healthcare Providers & Services industry, placing it in the top 30.2%.
Is Medicskin Holdings' FCF Margin % too high?
Medicskin Holdings' current FCF Margin % of 26.05% is 174% above median its 10-year median of 9.49. The Healthcare Providers & Services industry median FCF Margin % is 3.01. Medicskin Holdings' value of 26.05% is 766.9% above this industry median. Based on the distribution chart, Medicskin Holdings ranks #201 out of 666 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Medicskin Holdings has a GF Score™ of 54/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Medicskin Holdings' FCF Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Medicskin Holdings ranks #201 out of 666 companies for FCF Margin %. This puts Medicskin Holdings in the upper half of its industry. The industry median FCF Margin % is 3.01. Medicskin Holdings' value of 26.05% is 766.9% above this benchmark. While the company's 10-year median is 9.49 vs. the industry median of 3.01, Medicskin Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Healthcare Providers & Services company?
The median FCF Margin % among Healthcare Providers & Services companies is 3.01, based on 666 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medicskin Holdings's current FCF Margin % of 26.05% is 766.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Medicskin Holdings and its competitors. For the Healthcare Providers & Services industry, the median FCF Margin % is 3.01 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medicskin Holdings's current FCF Margin % is 26.05%, which is 174% above median its own 10-year median of 9.49. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medicskin Holdings stock overvalued right now?
Based on GuruFocus' analysis, Medicskin Holdings (HKSE:08307) is currently considered Possible Value Trap. The stock's GF Value™ is HK$0.18, compared to a current price of HK$0.12 — trading 31.7% below its estimated fair value. The current FCF Margin % is 26.05%, which is 174% above median its 10-year median of 9.49 and 766.9% above the Healthcare Providers & Services industry median of 3.01. Medicskin Holdings' overall GF Score™ is 54/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Medicskin Holdings (HKSE:08307), the current FCF Margin % is 26.05% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medicskin Holdings (HKSE:08307) Overvalued in 2026?
Based on GuruFocus' analysis, Medicskin Holdings stock appears to be undervalued.
The current stock price of HK$0.12 is trading 31.7% below its estimated GF Value™ of HK$0.18.
GuruFocus considers Medicskin Holdings to be Possible Value Trap.
Key valuation signals for HKSE:08307:
FCF Margin %: 26.05% (174% above median its 10-year median of 9.49)
GF Value™: HK$0.18 vs. price of HK$0.12 (31.7% below fair value)
Industry Position: 766.9% above the Healthcare Providers & Services median (#201 of 666)
No single metric tells the full story. See the HKSE:08307 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medicskin Holdings Ltd is a medical skin care service provider. It is engaged in providing services for inter alia, acne, pigmentation, rosacea, dermatitis, eczema and warts, skin rejuvenation, facial sculpturing and body contouring, treatment for acne scars and enlarged pores, removal of undesirable naevi, and hair removal. The company operates through a single segment namely Consultation Service, Prescription and Dispensing Service, and Treatment Services. The company offers services throughout Hong Kong.
54GF Score
Get the complete analysis for HKSE:08307
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:08307 has been successfully added to your 
